Total and Engie partner to develop France’s largest site for the production of green hydrogen January 13, 2021 PARIS: Total SE and Engie have signed a cooperation agreement to design, develop, build and operate the Masshylia project, France’s largest renewable hydrogen production…
Prodways Group records major successes in the field of medical applications January 13, 2021 PARIS: Prodways Group, specialist in digital design and manufacturing, announced major successes in the field of medical applications for its 3D Materials division. In…
Lleida.net receives its fourth patent from Chinese Intellectual Property Administration January 13, 2021 MADRID: The Chinese Intellectual Property Administration (CNIPA) has granted a new patent to Spanis digital signature company Lleida.net, for its method for producing electronic…
Solutions 30 signs a €210 million contract with Telecom Italia January 12, 2021 PARIS: Telecom Italia (TIM) has entrusted Solutions 30, with deploying its FTTH network in Piedmont and Aosta Valley. This contract opens up a new…
Atos to acquire In Fidem to reinforce its cybersecurity position in North America January 12, 2021 PARIS: Atos International has signed an agreement to acquire In Fidem, a Canada-based specialized cybersecurity consulting firm, a news release said. The closing of…
Lysogene gets MHRA and Research Ethics Committee approvals for Gene Therapy Clinical Trial in the UK January 11, 2021 PARIS: Lysogene, a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, has received MHRA and Research Ethics Committee approvals to…
Total acquires Fonroche Biogaz to become French leader in renewable gas January 11, 2021 PARIS: Total SE announced the acquisition of Fonroche Biogaz, a company that designs, builds and operates anaerobic digestion units in France. With close to…
Sanofi to acquire Kymab for an upfront payment of approximately $1.1 billion January 11, 2021 PARIS: Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics, have entered…
Valneva appoints Perry Celentano as interim COO, David Lawrence as acting CFO January 11, 2021 SAINT-HERBLAIN: Valneva SE a specialty vaccine company focused on prevention against diseases with major unmet needs, has appointed Perry Celentano as Chief Operating Officer…
Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO January 8, 2021 PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that…